Anton M. Bennett PhD
Associate Professor of Pharmacology and of Comparative Medicine; Co-Director, Program in Integrative Cell Signaling and Neurobiology of Metabolism; Director, BBS Minority Affairs
Departments & Organizations
Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development | Molecular Medicine, Pharmacology, and Physiology
Interdepartmental Neuroscience Program
Stem Cell Center, Yale: Tissue Specific Stem Cells
Vascular Biology and Therapeutics Program
Comparative Medicine: Integrative Cell Signaling & Neurobiology of Metabolism (ICSNM)
Pharmacology: Neuropharmacology | Bennett Lab
Diabetes Endocrinology Research Center
Yale Core Center for Musculoskeletal Disorders
Signal transduction; Protein tyrosine phosphatases; Cancer; Diabetes; Obesity; Muscle stem cells; Muscular dystrophy more...
- Ph.D., New York Medical College, 1993
- Roth Flach, R.J., Zhang, and Bennett, A.M. (2011) Loss of MAP Kinase Phosphatase-1 protects from hepatic steatosis by repression of CIDEC/Fat-specific protein 27, J. Biol. Chem., 286: 22195-22202.
- Diano, S., Liu, Z., Jeong, J. K., Dietrich, M. O., Ruan, H., Kim, E., Suyama, S., Kelly, K., Gyengesi, E., Arbiser, J. L., Belsham, D., Sarruf, D., Schwartz, M., Bennett, A. M., Shanabrough, M., Mobbs, C. V., Yang, X., Gao, X., and Horvath, T. L. (2011) Peroxisome proliferation-related hypothalamic control of ROS sets melanocortin tone and feeding in diet-induced obesity. Nature Medicine, 11: 1121-1129.
- Roth, R. and Bennett, A.M. (2010) Mitogen-Activated Protein Kinase Phosphatase-1 - A Potential Therapeutic Target In Metabolic Disease, Expert Opinion On Therapeutic Targets, 14:1323-32.